BIO LOGIC SYSTEMS CORP
SC 13G, 1997-02-12
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SEAGATE TECHNOLOGY INC, S-3, 1997-02-12
Next: BIO LOGIC SYSTEMS CORP, SC 13G, 1997-02-12



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934
                              (Amendment No. 12 )*



                             BIO-LOGIC SYSTEMS CORP.
- ----------------------------------------------------------------------------
                                (Name of Issuer)


                          COMMON STOCK, $.01 PAR VALUE
- ----------------------------------------------------------------------------
                         (Title of Class of Securities)


                                   090909 10 2
                                 --------------
                                 (CUSIP Number)


Check the following box if a fee is being paid with this statement     . (A fee
                                                                   ----
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                        (Continued on following page(s))
                                Page 1 of 4 Pages

<PAGE>
CUSIP No. 090909102                  13G                    Page 2 of 4 Pages
          ---------                                              --   --

                                                                           
   1.   NAME OF REPORTING PERSON
        S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

        GIL RAVIV, PH.D.


   2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                         (a)
                                                                ---
                                                         (b)
                                                                ---

   3.   SEC USE ONLY
               


   4.   CITIZENSHIP OR PLACE OF ORGANIZATION
    

        UNITED STATES


SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
- -------------------------------------------------------

   5.   SOLE VOTING POWER
    
        565,437 (SEE ITEM 4)



   6.   SHARED VOTING POWER 

        -0-

                                                                           
   7.   SOLE DISPOSITIVE POWER                                          

        565,437 (SEE ITEM 4)

                                                                           
   8.   SHARED DISPOSITIVE POWER
                                                                          
        -0-

                                                                           
   9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                                                           

        565,437 (SEE ITEM 4)
                                                                           
   10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
                                                                             
        SEE ITEM 4                                          X  
                                                           --- 
                                                               
   11.  PERCENTAGE CLASS REPRESENTED BY AMOUNT IN ROW 9
                                                               
        14.3%

                                                                             
   12.  TYPE OF REPORTING PERSON*
                                                                             
        IN

                                                             
                     *SEE INSTRUCTIONS BEFORE FILLING OUT!
                                                        
<PAGE>
                                                Page  3  of   4   Pages


Item 1(a).    Name of Issuer:  BIO-LOGIC SYSTEMS CORP.

Item 1(b).    Address of Issuer's Principal Executive Offices:  ONE BIO-LOGIC 
              PLAZA, MUNDELEIN, ILLINOIS  60060

Item 2(a).    Name of Person Filing:  GIL RAVIV, PH.D.

Item 2(b).    Address of Principal Business Office or if none, Residence:
              3633 WEST LAKE AVENUE, GLENVIEW, ILLINOIS  60025

Item 2(c).    Citizenship:  UNITED STATES

Item 2(d).    Title of Class of Securities:   COMMON STOCK, $.01 PAR VALUE

Item 2(e).    CUSIP Number:  090909 10 2

Item 3.       If this statement is filed pursuant to Rule 13d-1(b), or
              13d-2(b), check whether the person filing is a:

              INAPPLICABLE

Item 4.       Ownership:

         (a)  Amount Beneficially Owned:  AS OF DECEMBER 31, 1996, DR. RAVIV
              BENEFICIALLY OWNED 565,437 SHARES OF ISSUER'S COMMON STOCK, WHICH
              INCLUDES 2,750 SHARES UNDERLYING OPTIONS  EXERCISABLE WITHIN 60 
              DAYS, 111,000 SHARES BENEFICIALLY OWNED BY GIL RAVIV AS TRUSTEE 
              FOR THE GABRIEL RAVIV FAMILY TRUST AND 40,000 SHARES OWNED BY A 
              CORPORATION OF WHICH DR. RAVIV HAS APPROXIMATELY 42% OF THE 
              VOTING POWER.  THIS AMOUNT DOES NOT INCLUDE 4,250 SHARES 
              UNDERLYING OPTIONS NOT EXERCISABLE WITHIN 60 DAYS, 30,000 SHARES 
              BENEFICIALLY OWNED BY GABRIEL RAVIV AS TRUSTEE FOR THE GIL RAVIV 
              FAMILY TRUST OR 2,750 SHARES OWNED BY DR. RAVIV'S WIFE, AS TO 
              WHICH DR. RAVIV DISCLAIMS BENEFICIAL OWNERSHIP.

         (b)  Percent of Class:  14.3%

         (c)  Number of shares as to which such person has:

              (i)      sole power to vote or to direct the vote:  565,437
              (ii)     shared power to vote or to direct the vote:  0
              (iii)    sole power to dispose or to direct the disposition of:  
                       565,437
              (iv)     shared power to dispose of or to direct the disposition 
                       of:  0


<PAGE>
                                                Page  4  of   4   Pages



Item 5.      Ownership of Five Percent or Less of a Class

             INAPPLICABLE

Item 6.      Ownership of More than Five Percent on Behalf of Another Person

             INAPPLICABLE

Item 7.      Identification and Classification of Subsidiary Which Acquired the
             Securities

             INAPPLICABLE


Item 8.      Identification and Classification of Members of the Group

             INAPPLICABLE


Item 9.      Notice of Dissolution of Group

             INAPPLICABLE


Item 10.     Certification

             INAPPLICABLE


             After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.

February 11, 1997


By:   /S/ GIL RAVIV
     ----------------
     GIL RAVIV, PH.D.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission